Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on June 5, 2026

Jun. 5, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8

Indeterminate GlobeNewswire

Jun. 5, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity

Indeterminate GlobeNewswire

Jun. 5, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Jun. 5, 2026

Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Jun. 5, 2026

Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing

Indeterminate GlobeNewswire

Jun. 5, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Rivus Pharmaceuticals Announces Preclinical Data for RV-8451, a Muscle-Preserving, Oral GLP-1, at ADA 2026 Scientific Sessions

Indeterminate GlobeNewswire

Jun. 5, 2026

TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting

Indeterminate GlobeNewswire

Jun. 5, 2026

ANNULATION -- Association pour la santé publique du Québec

Indeterminate GlobeNewswire

Jun. 5, 2026

Victoire : un projet de loi vise à encadrer la vente des boissons énergisantes caféinées aux jeunes de moins de 16 ans

Indeterminate GlobeNewswire

Jun. 5, 2026

Parker Seminars Dallas Returns October 2-4, 2026, Bringing Together Leaders in Chiropractic, Healthcare, Business, and Innovation

Indeterminate GlobeNewswire

Jun. 5, 2026

CogniHoney Under Investigation: Shocking Cogni Honey Examining Customer Complaints, Ingredients Claims and Serious Side Effects Risk

Indeterminate GlobeNewswire

Jun. 5, 2026

EnGeneIC Honored with 2026 Breakthrough in Glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York

Indeterminate GlobeNewswire

Jun. 5, 2026

Vivex Biologics Publishes New Medicare Real-World Evidence Study Showing VIA Disc® NP Significantly Reduces Opioid Use, Imaging, and Conservative Care Utilization in Patients with Lumbar Discogenic Pain

Indeterminate GlobeNewswire

Jun. 5, 2026

Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease Chorea

Indeterminate GlobeNewswire

Jun. 5, 2026

Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

Indeterminate GlobeNewswire

Jun. 5, 2026

Nyxoah Annonce la Fixation du Prix de l'Offre Publique Souscrite de 95 millions $

Indeterminate GlobeNewswire

Jun. 5, 2026

Gift of Life Marrow Registry Gala Celebrates First-Time Meetings Between Two Transplant Recipients and Their Lifesaving Donors

Indeterminate GlobeNewswire